BMS-936559 (PD-L1 inhibitor)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-936559 (PD-L1 inhibitor), covering 2012-02-23 to 2012-02-23. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic Malignancy [Phase 1]